Why more than 55 cyclists are riding 1,800km in Japan for cancer support
Over 15 days, teams of Bristol Myers Squibb employees are taking on a long-distance cycling challenge to support cancer organisations across Asia Pacific – driven by personal stories of patients, survivors and loved ones.
More than 55 Bristol Myers Squibb (BMS) employees from seven countries, including Australia, China, and Singapore, are participating in the Continent 2 Continent 4 Cancer (C2C4C) Asia Pacific event to support cancer organizations in Asia Pacific. The 15-day cycling challenge, which began on October 6 and ends on October 20, will cover nearly 1,800km starting at Tokyo Bay and finishing in Otemachi, Tokyo.
Each participant will cover approximately 360km over three-day segments. Teams are training for five months alongside their work and personal commitments. Since 2021, C2C4C rides in Asia Pacific have raised over US$830,000 for UICC member organizations, with BMS pledging up to US$120,000 for this year's ride. This year's event marks the transition from C2C4C Japan to C2C4C Asia Pacific, bringing together BMS employees from across the region.
Cyclist Brad Cox is riding to honor his father, who passed away from a rare cancer last year. Team captain Kumiko Saito emphasizes the broader goal of supporting cancer patients and their families. BMS is also working to improve access to cancer treatment across Asia Pacific, including addressing the gap between disease progression and patient access to care, ensuring clinical research better represents Asian populations, and expanding access to CAR T-cell therapy for blood cancers in Japan.
Written by urgent.news from Channel News Asia's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
